Cargando…

Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer

PURPOSE: Previous studies of hypofractionated adjuvant whole-breast radiotherapy for early breast cancer established a 15- or 16-fraction (fr) regimen as standard. The FAST Trial (CRUKE/04/015) evaluated normal tissue effects (NTE) and disease outcomes after 5-fr regimens. Ten-year results are prese...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brunt, Adrian Murray, Haviland, Joanne S., Sydenham, Mark, Agrawal, Rajiv K., Algurafi, Hafiz, Alhasso, Abdulla, Barrett-Lee, Peter, Bliss, Peter, Bloomfield, David, Bowen, Joanna, Donovan, Ellen, Goodman, Andy, Harnett, Adrian, Hogg, Martin, Kumar, Sri, Passant, Helen, Quigley, Mary, Sherwin, Liz, Stewart, Alan, Syndikus, Isabel, Tremlett, Jean, Tsang, Yat, Venables, Karen, Wheatley, Duncan, Bliss, Judith M., Yarnold, John R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Clinical Oncology 2020
Materias:	ORIGINAL REPORTS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526720/ https://www.ncbi.nlm.nih.gov/pubmed/32663119 http://dx.doi.org/10.1200/JCO.19.02750

Ejemplares similares

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial
por: Murray Brunt, Adrian, et al.
Publicado: (2020)

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial
por: Coles, Charlotte E, et al.
Publicado: (2017)

Cost-effectiveness of 5 fraction and partial breast radiotherapy for early breast cancer in the UK: model-based multi-trial analysis
por: Glynn, David, et al.
Publicado: (2022)

Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials
por: Haviland, Joanne S, et al.
Publicado: (2018)

Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial
por: Brunt, A. Murray, et al.
Publicado: (2016)

Can patient-reported outcomes be used instead of clinician-reported outcomes and photographs as primary endpoints of late normal tissue effects in breast radiotherapy trials? Results from the IMPORT LOW trial
por: Bhattacharya, Indrani S., et al.
Publicado: (2019)

Hypofractionation: The standard for external beam breast irradiation
por: Brunt, Adrian Murray, et al.
Publicado: (2023)

Women's Free-text Comments on their Quality of Life: An Exploratory Analysis from the UK Standardisation of Breast Radiotherapy (START) Trials for Early Breast Cancer
por: Mills, J., et al.
Publicado: (2018)

Patient-Reported Outcomes Over 5 Years After Whole- or Partial-Breast Radiotherapy: Longitudinal Analysis of the IMPORT LOW (CRUK/06/003) Phase III Randomized Controlled Trial
por: Bhattacharya, Indrani S., et al.
Publicado: (2019)

Cytokine levels as biomarkers of radiation fibrosis in patients treated with breast radiotherapy
por: Westbury, Charlotte B, et al.
Publicado: (2014)

FFPE breast tumour blocks provide reliable sources of both germline and malignant DNA for investigation of genetic determinants of individual tumour responses to treatment
por: Wilkins, Anna, et al.
Publicado: (2018)

Is breast seroma after tumour resection associated with patient-reported breast appearance change following radiotherapy? Results from the IMPORT HIGH (CRUK/06/003) trial
por: Bhattacharya, Indrani S., et al.
Publicado: (2019)

Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients.
por: Shayeghi, M., et al.
Publicado: (1998)

Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial
por: Ellis, Paul, et al.
Publicado: (2009)

Changes in radiotherapy fractionation—breast cancer
por: Yarnold, John
Publicado: (2019)

Oral contraceptives and survival in breast cancer.
por: Millard, F. C., et al.
Publicado: (1987)

Minimising oncological treatment of early breast cancer
por: Yarnold, J
Publicado: (2008)

Can patient decision aids reduce decisional conflict in a de-escalation of breast radiotherapy clinical trial? The PRIMETIME Study Within a Trial implemented using a cluster stepped-wedge trial design
por: Bhattacharya, Indrani S., et al.
Publicado: (2021)

Macrophages in human breast disease: a quantitative immunohistochemical study.
por: Kelly, P. M., et al.
Publicado: (1988)

ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer
por: Pinhel, Isabel, et al.
Publicado: (2012)

The challenges of long-term follow-up data collection in non-commercial, academically-led breast cancer clinical trials: the UK perspective
por: Kilburn, Lucy S, et al.
Publicado: (2014)

Patient advocate involvement in the design and conduct of breast cancer clinical trials requiring the collection of multiple biopsies
por: Batten, Leona M., et al.
Publicado: (2018)

Bone marrow micrometastases in early breast cancer–30-year outcome
por: Mansi, J, et al.
Publicado: (2016)

Angiosarcoma of the Scalp Presenting in Association With Borderline Malignant Phyllodes Tumour of the Breast
por: Harden, Susan V., et al.
Publicado: (2003)

How do patients want to learn of results of clinical trials? A survey of 1431 breast cancer patients
por: Johnson, L, et al.
Publicado: (2008)

Diagnosis and treatment of early breast cancer, including locally advanced disease—summary of NICE guidance
por: Harnett, Adrian, et al.
Publicado: (2009)

The development of a DVD to aid patients’ understanding of surgical breast reconstruction clinical trials: QUEST Trials A & B
por: Mills, Judith, et al.
Publicado: (2011)

Can Interrogation of Tumour Characteristics Lead us to Safely Omit Adjuvant Radiotherapy in Patients with Early Breast Cancer?
por: Bhattacharya, I.S., et al.
Publicado: (2018)

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
por: Bartlett, Frederick R., et al.
Publicado: (2014)

Can routine data be used to support cancer clinical trials? A historical baseline on which to build: retrospective linkage of data from the TACT (CRUK 01/001) breast cancer trial and the National Cancer Data Repository
por: Kilburn, Lucy Suzanne, et al.
Publicado: (2017)

QUEST Perspective Study (QPS) to measure the understanding by patients and healthcare professionals of surgical breast reconstruction clinical trials: QUEST Trials A & B
por: Winters, Zoe E, et al.
Publicado: (2011)

International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic
por: Coles, C.E., et al.
Publicado: (2020)

Psychomotor Aspects of Mental Disease. An Experimental Study
por: Bliss, Eugene
Publicado: (1955)

Diabetes: its medical and cultural history:outlines, texts, bibliography
por: Bliss, Michael
Publicado: (1992)

Professional gentlemen: the professions in nineteenth-century Ontario
por: Bliss, Michael
Publicado: (1996)

Associated Medical Services, Incorporated: a history
por: Bliss, Michael
Publicado: (1989)

Book Reviews: Fatal Thirst: Diabetes in Britain Until Insulin
por: Bliss, Michael
Publicado: (2011)

Mr. Bliss's Observations on the Kilburn Water
por: Bliss, John
Publicado: (1801)

Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial
por: Cameron, David, et al.
Publicado: (2017)

A multicentre study of the evidence for customized margins in photon breast boost radiotherapy
por: Harris, Emma J, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1qgsqjr8qo92fv4n755stea3ch